Relationship between Sarcopenia and mTOR Pathway in Patients with Colorectal Cancer: Preliminary Report

References

• Argilés JM, Busquets S, Stemmler B, and López-Soriano FJ: Cachexia and sarcopenia: mechanisms and potential targets for intervention. Curr Opin Pharmacol 22, 100–106, 2015.
   PubMed Web of Science ®Google Scholar
• Cohen S, Nathan JA, and Goldberg AL: Muscle wasting in disease: molecular mechanisms and promising therapies. Nat Rev Drug Discov 14, 58–74, 2015.
   PubMed Web of Science ®Google Scholar
• Sandri M: Signaling in muscle atrophy and hypertrophy. Physiology (Bethesda) 23, 160–170, 2008.
   PubMed Web of Science ®Google Scholar
• Rodriguez J, Vernus B, Chelh I, Cassar-Malek I, Gabillard JC, et al.: Myostatin and the skeletal muscle atrophy and hypertrophy signaling pathways. Cell Mol Life Sci 71, 4361–4371, 2014.
   PubMed Web of Science ®Google Scholar
• Latres E, Amini AR, Amini AA, Griffiths J, Martin FJ, et al.: Insulin-like growth factor-1 (IGF-1) inversely regulates atrophy-induced genes via the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin (PI3K/Akt/mTOR) pathway. J Biol Chem 280, 2737–2744, 2005.
   PubMed Web of Science ®Google Scholar
• Lecker SH, Jagoe RT, Gilbert A, Gomes M, Baracos V, et al.: Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression. FASEB J 18, 39–51, 2004.
   PubMed Web of Science ®Google Scholar
• Bodine SC, Stitt TN, Gonzalez M, Kline WO, Stover GL, et al.: Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo. Nat Cell Biol 3, 1014–1019, 2001.
   PubMed Web of Science ®Google Scholar
• Pallafacchina G, Calabria E, Serrano AL, Kalhovde JM, and Schiaffino S: A protein kinase B-dependent and rapamycin-sensitive pathway controls skeletal muscle growth but not fiber type specification. Proc Natl Acad Sci USA 99, 9213–9218, 2002.
   PubMed Web of Science ®Google Scholar
• Egerman MA and Glass DJ: Signaling pathways controlling skeletal muscle mass. Crit Rev Biochem Mol Biol 49, 59–68, 2014.
   PubMed Web of Science ®Google Scholar
• D'Antona G and Nisoli E: mTOR signaling as a target of amino acid treatment of the age-related sarcopenia. Interdiscip Top Gerontol 37, 115–141, 2010.
   PubMedGoogle Scholar
• Mueller TC, Bachmann J, Prokopchuk O, Friess H, and Martignoni ME: Molecular pathways leading to loss of skeletal muscle mass in cancer cachexia–can findings from animal models be translated to humans? BMC Cancer 16, 75, 2016.
   PubMed Web of Science ®Google Scholar
• Mitsiopoulos N, Baumgartner RN, Heymsfield SB, Lyons W, Gallagher D, et al.: Cadaver validation of skeletal muscle measurement by magnetic resonance imaging and computerized tomography. J Appl Physiol 85, 115–122, 1998 (1985).
   PubMed Web of Science ®Google Scholar
• Prado CM, Lieffers JR, McCargar LJ, Reiman T, Sawyer MB, et al.: Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol 9, 629–635, 2008.
   PubMed Web of Science ®Google Scholar
• Mourtzakis M, Prado CM, Lieffers JR, Reiman T, McCargar LJ, et al.: A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care. Appl Physiol Nutr Metab 33, 997–1006, 2008.
   PubMed Web of Science ®Google Scholar
• Martin L, Birdsell L, Macdonald N, Reiman T, Clandinin MT, et al.: Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index. J Clin Oncol 31, 1539–1547, 2013.
   PubMed Web of Science ®Google Scholar
• Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, et al.: Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing 39, 412–423, 2010.
   PubMed Web of Science ®Google Scholar
• Lieffers JR, Bathe OF, Fassbender K, Winget M, and Baracos VE: Sarcopenia is associated with postoperative infection and delayed recovery from colorectal cancer resection surgery. Br J Cancer 107, 931–936, 2012.
   PubMed Web of Science ®Google Scholar
• Muscaritoli M, Anker SD, Argilés J, Aversa Z, Bauer JM, et al.: Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) "cachexia-anorexia in chronic wasting diseases" and "nutrition in geriatrics". Clin Nutr 29, 154–159, 2010.
   PubMed Web of Science ®Google Scholar
• Lauretani F, Russo CR, Bandinelli S, Bartali B, Cavazzini C, et al.: Age-associated changes in skeletal muscles and their effect on mobility: an operational diagnosis of sarcopenia. J Appl Physiol 95, 1851–1860, 2003 (1985).
   PubMed Web of Science ®Google Scholar
• Bielemann RM, Gigante DP, and Horta BL: Birth weight, intrauterine growth restriction and nutritional status in childhood in relation to grip strength in adults: from the 1982 Pelotas (Brazil) birth cohort. Nutrition 32, 228–235, 2016.
   PubMed Web of Science ®Google Scholar
• Stephens NA, Skipworth RJ, Gallagher IJ, Greig CA, Guttridge DC, et al.: Evaluating potential biomarkers of cachexia and survival in skeletal muscle of upper gastrointestinal cancer patients. J Cachexia Sarcopenia Muscle 6, 53–61, 2015.
   PubMed Web of Science ®Google Scholar
• Wacholder S, Silverman DT, McLaughlin JK, and Mandel JS: Selection of controls in case-control studies. III. Design options. Am J Epidemiol 135, 1042–1050, 1992.
   PubMed Web of Science ®Google Scholar
• Castaneda CA, Cortes-Funes H, Gomez HL, and Ciruelos EM: The phosphatidyl inositol 3-kinase/AKT signaling pathway in breast cancer. Cancer Metastasis Rev 29, 751–759, 2010.
   PubMed Web of Science ®Google Scholar
• Itoh N, Semba S, Ito M, Takeda H, Kawata S, and Yamakawa M: Phosphorylation of Akt/PKB is required for suppression of cancer cell apoptosis and tumor progression in human colorectal carcinoma. Cancer 94, 3127–3134, 2002.
   PubMed Web of Science ®Google Scholar
• Clark C, Shah S, Herman-Ferdinandez L, Ekshyyan O, Abreo F, et al.: Teasing out the best molecular marker in the AKT/mTOR pathway in head and neck squamous cell cancer patients. Laryngoscope 120, 1159–1165, 2010.
   PubMed Web of Science ®Google Scholar
• Lahat G, Dhuka AR, Hallevi H, Xiao L, Zou C, et al.: Angiosarcoma: clinical and molecular insights. Ann Surg 251, 1098–1106, 2010.
   PubMed Web of Science ®Google Scholar
• Agarwal R, Carey M, Hennessy B, and Mills GB: PI3K pathway-directed therapeutic strategies in cancer. Curr Opin Investig Drugs 11, 615–628, 2010.
   PubMedGoogle Scholar
• Phillips WA, St Clair F, Munday AD, Thomas RJ, and Mitchell CA: Increased levels of phosphatidylinositol 3-kinase activity in colorectal tumors. Cancer 83, 41–47, 1998.
   PubMed Web of Science ®Google Scholar
• Arcaro A and Guerreiro AS: The phosphoinositide 3-kinase pathway in human cancer: genetic alterations and therapeutic implications. Curr Genomics 8, 271–306, 2007.
   PubMed Web of Science ®Google Scholar
• Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, et al.: Definition and classification of cancer cachexia: an international consensus. Lancet Oncol 12, 489–495, 2011.
   PubMed Web of Science ®Google Scholar
• Fielding RA, Vellas B, Evans WJ, Bhasin S, Morley JE, et al.: Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. J Am Med Dir Assoc 12, 249–256, 2011.
   PubMed Web of Science ®Google Scholar
• Maurício SF, Xiao J, Prado CM, Gonzalez MC, and Correia MITD: Different nutritional assessment tools as predictors of postoperative complications in patients undergoing colorectal cancer resection. Clin Nutr 37, 1505–1511,2018.
   Google Scholar
• Fearon K, Arends J, and Baracos V: Understanding the mechanisms and treatment options in cancer cachexia. Nat Rev Clin Oncol 10, 90–99, 2013.
   PubMed Web of Science ®Google Scholar
• Madeddu C, Mantovani G, Gramignano G, Astara G, and Macciò A: Muscle wasting as main evidence of energy impairment in cancer cachexia: future therapeutic approaches. Future Oncol 11, 2697–2710, 2015.
   PubMed Web of Science ®Google Scholar